Week Ahead In Pharma: Data Readouts At WORLDSymposium, TCT Meetings & GU Cancers Symposium

(RTTNews) – In the trading week ended February 5, a couple of Alzheimer’s treatment stocks staged big gains, thanks to Cassava Sciences Inc. (SAVA) reporting encouraging data of its lead Alzheimer’s drug candidate Simufilam on February 2.Cassava was up over 126% for the week whilRead MoreMarketsMarkets Feed